Semaglutide
FDA ApprovedSemaglutide
- Category
- Weight Loss & Metabolism
- Aliases
- Ozempic, Wegovy, Rybelsus
- Administration
- Subcutaneous injection (weekly), Oral tablet (daily)
Documented side effects
Tier 1 · Peer-reviewed / regulatoryGI symptoms (most common)
Nausea, vomiting, or diarrhea are the most frequently reported effects, especially when starting or increasing the dose.
Rare pancreatitis
An uncommon but serious inflammation of the pancreas has been reported in rare cases.